[Young, fit, nonsmoker-That is also typical in lung cancer!]

Sabine Hatzfeld1, Bärbel Söhlke2

  • 1zielGENau e. V., Kerpener Str. 62, 50937, Köln, Deutschland. sabine.hatzfeld@zielgenau.org.

Insights

Lung cancer affects younger, non-smoking individuals with treatable mutations. Early molecular genetic testing and targeted therapies, facilitated by networks like the national network of genomic medicine (nNGM), improve patient survival and outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Diagnostics

Background:

  • Lung cancer presentation extends beyond elderly smokers, including younger non-smokers with actionable mutations.
  • Targeted therapies offer significant survival benefits over traditional treatments for specific patient subsets.
  • Current adoption rates for molecular genetic testing and targeted treatments are increasing but remain suboptimal.

Purpose of the Study:

  • To highlight the need for broader access to molecular diagnostics and targeted therapies in lung cancer.
  • To emphasize the importance of a research-integrated network for ensuring diagnostic and therapeutic quality.
  • To showcase the national network of genomic medicine (nNGM) as a model for collaborative lung cancer care.

Main Methods:

  • Analysis of current trends in molecular genetic testing and targeted treatment uptake in lung cancer.
  • Evaluation of the structure and function of the national network of genomic medicine (nNGM).
  • Assessment of patient engagement and its impact on healthcare system participation.

Main Results:

  • The national network of genomic medicine (nNGM) demonstrates successful cooperation in lung cancer care.
  • The nNGM facilitates patient participation, leading to longer survival and increased patient voice.
  • Well-informed patients are better positioned to benefit from diagnostic and therapeutic advancements.

Conclusions:

  • A structured, research-adjacent network is crucial for equitable access to modern lung cancer diagnostics and treatments.
  • The nNGM model effectively integrates research, diagnostics, and patient advocacy.
  • Empowered and informed patients are key drivers for advancing lung cancer care and outcomes.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
485
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
899
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
507
Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
51.3K
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
117